<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="39868" whole_study_id="39868" phs="002402" v="1" p="1" createDate="2020-11-05T08:46:54-05:00" completedByGPADate="2021-04-01T12:07:59-05:00" modDate="2022-01-25T16:16:24-05:00" maxParentChildStudyModDate="2022-01-25T16:16:24-05:00" num_participants="1057"><StudyInfo accession="phs002402.v1.p1" parentAccession="phs002402.v1.p1"><BioProject id="PRJNA722325" entrez_id="722325" type="bp_admin_access"/><BioProject id="PRJNA722326" entrez_id="722326" type="bp_data_submission"/><StudyNameEntrez>Effects of Rare Variants and Ancestry on Beta Agonist Response In Asthma and COPD</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>dna</StudyType><StudyType>targeted_genome</StudyType></StudyTypes><Funding>R01HL142992</Funding></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="VORTEGA" aid="2" auth="eRA" login="VORTEGA" fname="Victor" mname="" lname="Ortega" email="Ortega.Victor@mayo.edu"><Role allow_direct_access="true">PI</Role><Organization>WAKE FOREST UNIVERSITY HEALTH SCIENCESMAYO CLINIC ARIZONA</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Elizabeth" lname="Ampleford" email="eamplfo@wakehealth.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>Whole-genome genotyping data from the AsthmaNet Best African American Response to Asthma Drugs (BARD) trial (Wechsler M, et al. N Engl J Med 2020; ClinicalTrials.gov Identifier NCT1967173) was supported by NIH NHLBI grant U10 HL098115, HL098102, HL098096, HL098075, HL098090, HL098177, HL098098, HL098107, HL098112, HL098103 and the clinical protocol development led by Drs. Michael Wechsler, Stan Szefler, and Elliot Israel. Whole-genome genotyping, genetic ancestry, and pharmacogenetic protocols of BARD were developed and led by Drs. Deborah Meyers, Eugene Bleecker, and Victor Ortega and targeted gene sequencing was supported by R01 HL142992. 
AsthmaNet BARD investigators include the following: Michael E. Wechsler, M.D., Stanley J. Szefler, M.D., Victor E. Ortega, M.D., Ph.D., Jacqueline A. Pongracic, M.D., Vernon Chinchilli, Ph.D., John J. Lima, Pharm.D., Jerry A. Krishnan, M.D., Ph.D., Susan J. Kunselman, M.S., David Mauger, Ph.D., Eugene R. Bleecker, M.D., Leonard B. Bacharier, M.D., Avraham Beigelman, M.D., Mindy Benson, M.S.N., P.N.P., Kathryn V. Blake, Pharm.D., Michael D. Cabana, M.D., M.P.H., Juan&#8209;Carlos Cardet, M.D., M.P.H., Mario Castro, M.D., M.P.H., James F. Chmiel, M.D., Ronina Covar, M.D., Loren Denlinger, M.D., Ph.D., Emily DiMango, M.D., Anne M. Fitzpatrick, Ph.D., Deborah Gentile, M.D., Nicole Grossman, M.D., Fernando Holguin, M.D., M.P.H., Daniel J. Jackson, M.D., Harsha Kumar, M.D., Monica Kraft, M.D., Craig F. LaForce, M.D., Jason Lang, M.D., Stephen C. Lazarus, M.D., Robert F. Lemanske, Jr., M.D., Dayna Long, M.D., Njira Lugogo, M.D., Fernando Martinez, M.D., Deborah A. Meyers, Ph.D., Wendy C. Moore, M.D., James Moy, M.D., Edward Naureckas, M.D., J. Tod Olin, M.D., Stephen P. Peters, M.D., Ph.D., Wanda Phipatanakul, M.D., Loretta Que, M.D., Hengameh Raissy, Pharm.D., Rachel G. Robison, M.D., Kristie Ross, M.D., William Sheehan, M.D., Lewis J. Smith, M.D., Julian Solway, M.D., Christine A. Sorkness, Pharm.D., Lisa Sullivan&#8209;Vedder, M.D., Sally Wenzel, M.D., Steven White, M.D., and Elliot Israel, M.D.
Investigator affiliations are as follows: National Jewish Health (M.E.W., R.C., J.T.O.), Denver, and University of Colorado School of Medicine (M.E.W., S.J.S., R.C., F.H., J.T.O.) and Children&#8217;s Hospital Colorado (S.J.S.), Aurora &#8212; all in Colorado; Wake Forest School of Medicine (V.E.O., W.C.M., S.P.P.), Winston-Salem, North Carolina Clinical Research (C.F.L.), Raleigh, and Duke University Medical Center (N.L., L.Q.), Durham &#8212; all in North Carolina; Ann and Robert H. Lurie Children&#8217;s Hospital of Chicago (J.A.P., R.G.R.), University of Illinois at Chicago (J.A.K., H.K.), Rush University Medical Center (J.M.), University of Chicago (E.N., J.S., S. White), and Northwestern University Feinberg School of Medicine (L.J.S.) &#8212; all in Chicago; Penn State University (V.C., S.J.K., D.M.), Hershey, and Allegheny General Hospital (D.G.) and University of Pittsburgh Medical Center (S. Wenzel), Pittsburgh &#8212; all in Pennsylvania; Nemours Children&#8217;s Health System, Jacksonville (J.J.L., K.V.B., J.L.), and University of South Florida Morsani College of Medicine, Tampa (J.-C.C.) &#8212; both in Florida; University of Arizona Health Sciences, Tucson (E.R.B., M.K., F.M., D.A.M.); Washington University School of Medicine, St. Louis (L.B.B., A.B., M.C.); University of California, San Francisco (UCSF), San Francisco (M.B., M.D.C., S.C.L., D.L.) and
UCSF Benioff Children&#8217;s Hospital, Oakland (M.B., D.L.) &#8212; both in California; Brigham and Women&#8217;s Hospital and Harvard Medical School (J.-C.C., N.G., E.I.) and Boston Children&#8217;s Hospital (W.P., W.S.) &#8212; all in Boston; University Hospitals Rainbow Babies and Children&#8217;s Hospital, Case Western Reserve University School of Medicine, Cleveland (J.F.C., K.R.); University of Wisconsin&#8211;Madison, Madison (L.D., D.J.J., R.F.L., C.A.S.) and Aurora Sinai Medical Center, Milwaukee (L.S.-V.) &#8212; both in Wisconsin; Columbia University Irving Medical Center, New York, (E.D.); Emory University, Atlanta (A.M.F.); and University of New Mexico, Albuquerque (H.R.).

Whole-genome genotyping and the resulting data from the trial cohort entitled &#8220;A Comparison of SYMBICORT&#174; pMDI With Budesonide HFA pMDI in African American Subjects With Asthma&#8221; was supported by a contract from Astra Zeneca and led by Drs. Victor Ortega, Eugene R. Bleecker, and Deborah A. Meyers at the Wake Forest School of Medicine. Targeted gene sequencing was supported by R01 HL142992. DNA samples and phenotype data were provided by investigators from AstraZeneca: Katarina Emanuelsson, Kristina Sandin, Christina Keen, and Carin Jorup.

The original data can be found in the NIH database for Genotypes and Phenotypes (dbGaP) phs_________(TBD).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="4458" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="4458"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study></dbgapss>